Literature DB >> 6639235

Bacteremic pneumonia due to gram-negative bacilli.

J P Phair, H P Bassaris, J E Williams, E Metzger.   

Abstract

Bacteremic pneumonia due to aerobic gram-negative bacilli was diagnosed in 27 patients during a 20-month period. The mortality was high (81.5%) among these elderly patients (mean age, 61.2 years) with serious underlying disease, in spite of amikacin sulfate therapy that was appropriate as determined by susceptibility testing. Bacteremic pneumonia accounted for 14.1% of patients with gram-negative bacteremia but was responsible for 39.4% of the deaths in the total group of 191 patients. The worsened prognosis of patients with pneumonia was unrelated to the species of infecting organisms or the underlying conditions or disease.

Entities:  

Mesh:

Year:  1983        PMID: 6639235

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  5 in total

1.  Virulence properties of Pseudomonas aeruginosa lacking the extreme-stress sigma factor AlgU (sigmaE).

Authors:  H Yu; J C Boucher; N S Hibler; V Deretic
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Emerging pathogens in nosocomial pneumonia.

Authors:  S L Berk; A Verghese
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-01       Impact factor: 3.267

3.  Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia.

Authors:  L A Cone; D R Woodard; D S Stoltzman; R G Byrd
Journal:  Antimicrob Agents Chemother       Date:  1985-07       Impact factor: 5.191

4.  Population-based study of the epidemiology and the risk factors for Pseudomonas aeruginosa bloodstream infection.

Authors:  M D Parkins; D B Gregson; J D D Pitout; T Ross; K B Laupland
Journal:  Infection       Date:  2009-12-12       Impact factor: 3.553

5.  Avirulence and altered physiological properties of cystic fibrosis strains of Pseudomonas aeruginosa.

Authors:  M A Luzar; T C Montie
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.